Jazz Pharmaceuticals plc (JAZZ)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

FIFTH FLOOR, WATERLOO EXCHANGE DUBLIN, IRELAND 4

Jazz Pharmaceuticals, Inc. focuses on identifying, developing, and commercializing products for neurology and psychiatry primarily in the United States. Its products include Xyrem for the treatment of cataplexy and excessive daytime sleepiness in patients with narcolepsy; Cystadane for the treatment of homocystinuria, an inherited metabolic disease; and Antizol to treat ethylene glycol and methanol poisoning. Its late-stage product candidates comprise Luvox CR, an extended release formulation of fluvoxamine, a selective serotonin reuptake inhibitor, which is used for the treatment of obsessive compulsive disorder and social anxiety disorder; and JZP-6, a liquid dosage form of sodium oxybate in Xyrem, for the treatment of fibromyalgia syndrome. The company's products in the clinical pipeline include JZP-4, a controlled release formulation of an anticonvulsant for the treatment of epilepsy and bipolar disorder; and JZP-8, a formulation incorporating a benzodiazepine, for the treatment of acute repetitive seizure clusters in refractory epilepsy patients. Its pipeline also comprise JZP-7, a formulation incorporating a dopamine agonist for the treatment of restless legs syndrome; and JZP-2, a formulation of a benzodiazepine for the acute treatment of panic attacks associated with panic disorder. The company has a product development and license agreement with Antares Pharma, Inc.

Data as of 2021-05-08 10:22:30 -0400
Market Cap9.933 Billion Shares Outstanding56.896 Million Avg 30-day Volume757.042 Thousand
P/E Ratio19.16617 Dividend Yield EPS9.07
Price/Sales4.08 Debt to Equity1.78 EBITDA1.045 Billion
Price to Book Value2.62 Forward PE11.48 Enterprise Value9.603 Billion
Total Cash2.433 Billion Current Debt752.093 Million Gross Profit2.276 Billion
BETA0.72972 52-week High/Low178.64 / 101.81 Next Earnings Date2021-08-03 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from JAZZ instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 8 7 14.29% 7 (0.42%) 6 (0.37%) 16.67%
Funds Holding: 427 381 12.07% 100 (6.01%) 91 (5.66%) 9.89%
13F shares: 52.612 Million 53.876 Million -2.35% 17.615 Million 19.83 Million -11.17%
% Ownership 94.4323 96.7017 -2.35% 31.6161 35.5929 -11.17%
New Positions: 79 65 21.54% 21 13 61.54%
Increased Positions 130 118 10.17% 27 26 3.85%
Closed Positions 30 55 -45.45% 12 19 -36.84%
Reduced Positions 168 151 11.26% 42 45 -6.67%
Total Calls 688.38 Thousand 797.158 Thousand -13.65% 265.9 Thousand 371.6 Thousand -28.44%
Total Puts 444.238 Thousand 692.157 Thousand -35.82% 109.8 Thousand 286.7 Thousand -61.7%
PUT/CALL Ratio 0.65 0.87 -25.29% 0.41 0.77 -46.75%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding JAZZ (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding JAZZ BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

3.5 Thousand total shares from 3 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

TOVEY CHRISTOPHER J. EVP COO & MANAGING DIR EUR/INT

  • Officer
25 2021-05-05 2

COZADD BRUCE C CHAIRMAN & CEO

  • Officer
  • Director
321,341 2021-05-03 12

GALA RENEE D EVP & CFO

  • Officer
25,347 2021-04-05 2

CARR PATRICIA VP, FINANCE & PAO

  • Officer
6,045 2021-03-08 6

LARKIN FINBAR SVP, TECHNICAL OPERATIONS

  • Officer
16,519 2021-03-08 4

SWISHER DANIEL N JR PRESIDENT AND COO

  • Officer
49,961 2021-03-05 3

IANNONE ROBERT EVP R&D, CHIEF MEDICAL OFFICER

  • Officer
30,145 2021-03-05 3

PATIL NEENA M SVP, GENERAL COUNSEL

  • Officer
26,147 2021-03-05 3

PEARCE SAMANTHA SVP, HEAD OF EUROPE & INTL

  • Officer
11,958 2021-03-05 2

SABLICH KIM EVP & GM, NORTH AMERICA

  • Officer
25,335 2021-02-25 3

SMITH MARK DOUGLAS

  • Director
9,065 2021-02-25 2

COOK JENNIFER E.

  • Director
9,065 2021-02-25 2

ENRIGHT PATRICK G

  • Director
20,368 2020-11-12 3

O'KEEFE KENNETH W

  • Director
23,112 2020-11-05 3

SOHN CATHERINE A.

  • Director
10,622 2020-11-04 2

BERNS PAUL L

  • Director
9,740 2020-11-02 2

WINNINGHAM RICK E

  • Director
6,198 2020-08-06 1

MULLIGAN SEAMUS

  • Director
1,155,493 2020-08-06 2

MCSHARRY HEATHER ANN

  • Director
10,333 2020-08-06 1

GRAY PETER

  • Director
12,020 2020-08-06 1

RIEDEL NORBERT G

  • Director
9,459 2020-08-06 1

SCHNEE ELMAR

  • Director
9,902 2020-08-06 1

ORIORDAN ANNE

  • Director
7,465 2020-08-06 1

MILLER MICHAEL PATRICK EVP, US COMMERCIAL

  • Officer
22,118 2020-03-12 0

TREACY PAUL SVP, TECHNICAL OPERATIONS

  • Officer
16,524 2019-08-12 0

WILSON KAREN J SVP, FINANCE & PAO

  • Officer
18,385 2019-03-05 0

YOUNG MATTHEW P. EVP & CFO

  • Officer
36,200 2019-03-05 0

MCGILL IAIN SVP, EUROPE & REST OF WORLD

  • Officer
24,938 2019-03-05 0

HOOPER SUZANNE SAWOCHKA EVP & GENERAL COUNSEL

  • Officer
39,738 2019-02-25 0

SMITH KAREN L. EVP, R&D AND CMO

  • Officer
28,474 2018-03-05 0

COX RUSSELL J. EVP & COO

  • Officer
102,821 2017-12-11 0

TOBIAS JEFFREY K EVP, R&D & CMO

  • Officer
38,484 2015-03-05 0

KEEGAN FINTAN EVP, TECHNICAL OPERATIONS

  • Officer
31,750 2014-07-08 0

FALBERG KATHRYN E EVP AND CFO

  • Officer
133,387 2014-03-05 0

MOMTAZEE JAMES C

  • Director
17,315 2013-08-13 0

KKR JP III LLC

KKR PARTNERS III, L.P.

KKR III GP LLC

KRAVIS HENRY R

ROBERTS GEORGE R

  • 10% Owner
  • SEE FOOTNOTES (1) - (6)SEE FOOTNOTES (1) - (6)SEE FOOTNOTES (1) - (6)SEE FOOTNOTES (1) - (6)SEE FOOTNOTES (1) - (6)
No longer subject to file 2013-03-08 0

KKR FUND HOLDINGS L.P.

KKR JP LLC

KKR MILLENNIUM FUND L.P.

KKR ASSOCIATES MILLENNIUM L.P.

KKR MILLENNIUM GP LLC

KKR FUND HOLDINGS GP LTD

KKR GROUP HOLDINGS L.P.

KKR GROUP LTD

KKR & CO. L.P.

KKR MANAGEMENT LLC

  • 10% Owner
  • SEE FOOTNOTES (1) - (6)SEE FOOTNOTES (1) - (6)SEE FOOTNOTES (1) - (6)SEE FOOTNOTES (1) - (6)SEE FOOTNOTES (1) - (6)SEE FOOTNOTES (1) - (6)SEE FOOTNOTES (1) - (6)SEE FOOTNOTES (1) - (6)SEE FOOTNOTES (1) - (6)SEE FOOTNOTES (1) - (6)
No longer subject to file 2013-03-08 0

SEBULSKY ALAN

  • Director
54,355 2012-03-09 0

CRESSEY BRYAN C

  • Director
  • SEE FOOTNOTES (1) (2)
1,497,477 2012-03-09 0

GAMBLE CAROL A SVP AND GENERAL COUNSEL

  • Officer
No longer subject to file 2012-03-09 0

MICHELSON MICHAEL W

  • Director
No longer subject to file 2012-01-11 0

COLELLA SAMUEL D

  • Director
No longer subject to file 2012-01-11 0

DESJARDIN MICHAEL A. SVP, PRODUCT DEVELOPMENT

  • Officer
14,574 2011-08-13 0

ELLER MARK G. SVP, RESEARCH & CLINICAL DEV.

  • Officer
4,151 2011-08-13 0

KKR GROUP HOLDINGS L.P.

KKR GROUP LTD

KKR & CO. L.P.

KKR MANAGEMENT LLC

KRAVIS HENRY R

ROBERTS GEORGE R

  • 10% Owner
  • SEE FOOTNOTES (2) - (9)SEE FOOTNOTES (2) - (9)SEE FOOTNOTES (2) - (9)SEE FOOTNOTES (2) - (9)SEE FOOTNOTES (2) - (9)SEE FOOTNOTES (2) - (9)
9,942,946 2011-07-29 0

KKR FINANCIAL HOLDINGS III, LLC

KKR FINANCIAL HOLDINGS LLC

KKR FINANCIAL ADVISORS LLC

KOHLBERG KRAVIS ROBERTS & CO.

KKR MANAGEMENT HOLDINGS L.P.

KKR MANAGEMENT HOLDINGS CORP

KKR ASSET MANAGEMENT LLC

  • SEE FOOTNOTES (2) - (9)SEE FOOTNOTES (2) - (9)SEE FOOTNOTES (2) - (9)SEE FOOTNOTES (2) - (9)SEE FOOTNOTES (2) - (9)SEE FOOTNOTES (2) - (9)SEE FOOTNOTES (2) - (9)
No longer subject to file 2011-07-29 0

WISSEL JANNE LT SVP, CHIEF REGULATORY OFFICER

  • Officer
48,544 2011-05-31 0

ZILKHA NATHANIEL M

  • Director
0 2011-03-10 0

MYERS ROBERT M PRESIDENT

  • Officer
  • Director
156,898 2010-11-30 0

COLLIGAN JOAN PRINCIPAL ACCOUNTING OFFICER

  • Officer
14,424 2010-11-30 0

TANANBAUM JAMES B

  • Director
0 2010-08-25 0

KKR FUND HOLDINGS L.P.

KKR FUND HOLDINGS GP LTD

KKR MANAGEMENT HOLDINGS L.P.

KKR MANAGEMENT HOLDINGS CORP

KKR GROUP HOLDINGS L.P.

KKR GROUP LTD

KKR & CO. L.P.

KKR MANAGEMENT LLC

  • 10% Owner
10,504,338 2009-10-01 0

SAKS SAMUEL R CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2009-01-21 0

FUST MATTHEW K EVP, CHIEF FINANCIAL OFFICER

  • Officer
58,948 2008-11-28 0

ALBERT E ALEXANDER

  • Director
0 2008-08-15 0

RAETHER PAUL E

HUTH JOHANNES P

FISHER TODD A

GORENFLOS REINHARD

GARAIALDE JACQUES

CALBERT MICHAEL M

NUTTALL SCOTT C

NAVAB ALEXANDAR JR

LIPSCHULTZ MARC S

GOLKIN PERRY

  • SEE FOOTNOTES (2) - (7)SEE FOOTNOTESSEE FOOTNOTESSEE FOOTNOTESSEE FOOTNOTESSEE FOOTNOTESSEE FOOTNOTESSEE FOOTNOTESSEE FOOTNOTESSEE FOOTNOTES
9,942,946 2008-07-21 0

KKR JP LLC

KKR JP III LLC

KKR III GP LLC

KKR ASSOCIATES MILLENNIUM L.P.

KKR PARTNERS III, L.P.

KKR MILLENNIUM FUND L.P.

KKR MILLENNIUM GP LLC

KRAVIS HENRY R

ROBERTS GEORGE R

GREENE JAMES H JR

  • SEE FOOTNOTES (2) - (7)SEE FOOTNOTESSEE FOOTNOTES (2) - (7)SEE FOOTNOTES (2) - (7)SEE FOOTNOTES (2) - (7)SEE FOOTNOTES (2) - (7)SEE FOOTNOTES (2) - (7)SEE FOOTNOTES (2) - (7)SEE FOOTNOTES (2) - (7)SEE FOOTNOTES (2) - (7)
9,942,946 2008-07-21 0

KKR JP LLC

KKR JP III LLC

KKR III GP LLC

KKR ASSOCIATES MILLENNIUM L.P.

KKR PARTNERS III, L.P.

KKR MILLENNIUM FUND L.P.

KKR MILLENNIUM GP LLC

LIPSCHULTZ MARC S

ROBERTS GEORGE R

GREENE JAMES H JR

  • SEE FOOTNOTES (2) - (7)SEE FOOTNOTES (2) - (7)SEE FOOTNOTES (2) - (7)SEE FOOTNOTES (2) - (7)SEE FOOTNOTES (2) - (7)SEE FOOTNOTES (2) - (7)SEE FOOTNOTES (2) - (7)SEE FOOTNOTES (2) - (7)SEE FOOTNOTES (2) - (7)SEE FOOTNOTES (2) - (7)
9,942,946 2008-07-21 0

MICHELSON MICHAEL W

JANETSCHEK WILLIAM J

  • Director
  • SEE FOOTNOTES (2) - (7)SEE FOOTNOTES (2) - (7)
9,942,946 2008-07-21 0

JANETSCHEK WILLIAM J

  • SEE FOOTNOTES 1-7
8,577,974 2008-04-24 0

BRIDGER MANAGEMENT LLC

MIGNONE ROBERTO

BRIDGER CAPITAL LLC

SWIFTCURRENT PARTNERS

SWIFTCURRENT OFFSHORE LTD

  • 10% Owner
2,667,050 2008-04-14 0

KRAVIS HENRY R

ROBERTS GEORGE R

GREENE JAMES H JR

  • SEE FOOTNOTES (2)(3)(4) & (5)SEE FOOTNOTES (2)(3)(4) & (5)SEE FOOTNOTES (2)(3)(4) & (5)
0 2008-03-12 0

MICHELSON MICHAEL W

KKR FINANCIAL HOLDINGS III, LLC

KKR FINANCIAL HOLDINGS LLC

KKR FINANCIAL ADVISORS LLC

KKR FINANCIAL LLC

KOHLBERG KRAVIS ROBERTS & CO.

KKR & CO. LLC

MOMTAZEE JAMES C

JAIMIN PATEL

NATHANIEL M ZILKHA

  • Director
  • SEE FOOTNOTES (2)(3)(4) & (5)SEE FOOTNOTES (2)(3)(4) & (5)SEE FOOTNOTES (2)(3)(4) & (5)SEE FOOTNOTES (2)(3)(4) & (5)SEE FOOTNOTES (2)(3)(4) & (5)SEE FOOTNOTES (2)(3)(4) & (5)SEE FOOTNOTES (2)(3)(4) & (5)SEE FOOTNOTES (2)(3)(4) & (5)SEE FOOTNOTES (2)(3)(4) & (5)SEE FOOTNOTES (2)(3)(4) & (5)
0 2008-03-12 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

TOVEY CHRISTOPHER J. - Officer EVP COO & MANAGING DIR EUR/INT

2021-05-07 16:46:03 -0400 2021-05-05 A 9,091 a 9,116 direct

COZADD BRUCE C - Director - Officer CHAIRMAN & CEO

2021-05-05 19:03:18 -0400 2021-05-05 S 500 $170.00 d 321,341 direct yes 1.0125 1.0125 2 0.0 1

COZADD BRUCE C - Director - Officer CHAIRMAN & CEO

2021-05-05 19:03:18 -0400 2021-05-03 S 1,500 $164.24 d 321,841 direct yes 1.0125 1.0125 2 0.0 1

GALA RENEE D - Officer EVP & CFO

2021-04-07 17:32:21 -0400 2021-04-05 F 1,515 $164.71 d 25,347 direct 0.2858 4.6291 4.6291 6 0.0 1

COZADD BRUCE C - Director - Officer CHAIRMAN & CEO

2021-04-06 18:13:54 -0400 2021-04-01 S 1,500 $164.96 d 323,341 direct yes -0.6114 2.7419 2.7419 6 -0.6114 2

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
JAZZ PHARMACEUTICALS PLC JAZZ 2021-05-11 22:15:03 UTC -0.2 0.25 2400000
JAZZ PHARMACEUTICALS PLC JAZZ 2021-05-11 21:45:03 UTC -0.2 0.25 2400000
JAZZ PHARMACEUTICALS PLC JAZZ 2021-05-11 21:15:03 UTC -0.2 0.25 2400000
JAZZ PHARMACEUTICALS PLC JAZZ 2021-05-11 20:45:03 UTC -0.2 0.25 2400000
JAZZ PHARMACEUTICALS PLC JAZZ 2021-05-11 20:15:03 UTC -0.2 0.25 2400000
JAZZ PHARMACEUTICALS PLC JAZZ 2021-05-11 19:45:03 UTC -0.2 0.25 2400000
JAZZ PHARMACEUTICALS PLC JAZZ 2021-05-11 19:15:02 UTC -0.2 0.25 2400000
JAZZ PHARMACEUTICALS PLC JAZZ 2021-05-11 18:45:02 UTC -0.2 0.25 2400000
JAZZ PHARMACEUTICALS PLC JAZZ 2021-05-11 18:15:03 UTC -0.2 0.25 2400000
JAZZ PHARMACEUTICALS PLC JAZZ 2021-05-11 17:45:03 UTC -0.2 0.25 2400000
JAZZ PHARMACEUTICALS PLC JAZZ 2021-05-11 17:15:04 UTC -0.2 0.25 2400000
JAZZ PHARMACEUTICALS PLC JAZZ 2021-05-11 16:45:04 UTC -0.2 0.25 2400000
JAZZ PHARMACEUTICALS PLC JAZZ 2021-05-11 16:15:04 UTC -0.2 0.25 2400000
JAZZ PHARMACEUTICALS PLC JAZZ 2021-05-11 15:45:03 UTC -0.2 0.25 2400000
JAZZ PHARMACEUTICALS PLC JAZZ 2021-05-11 15:15:03 UTC -0.2 0.25 2400000
JAZZ PHARMACEUTICALS PLC JAZZ 2021-05-11 14:45:03 UTC -0.2 0.25 2400000
JAZZ PHARMACEUTICALS PLC JAZZ 2021-05-11 14:15:03 UTC -0.2 0.25 2400000
JAZZ PHARMACEUTICALS PLC JAZZ 2021-05-11 13:45:04 UTC -0.2 0.25 2400000
JAZZ PHARMACEUTICALS PLC JAZZ 2021-05-11 13:15:04 UTC -0.2 0.25 2400000
JAZZ PHARMACEUTICALS PLC JAZZ 2021-05-11 12:45:03 UTC -0.2 0.25 2400000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
AGF Investments Trust- AGFIQ U.S. Market Neutral Momentum Fund JAZZ -164.0 shares, $-27068.2 2020-12-31 N-PORT
THE LAZARD FUNDS, INC.- Lazard Enhanced Opportunities Portfolio JAZZ -730.0 shares, $-120486.5 2020-12-31 N-PORT
JNL Series Trust- JNL Multi-Manager Alternative Fund JAZZ -5077.0 shares, $-837958.85 2020-12-31 N-PORT
FundVantage Trust- Gotham Enhanced Index Plus Fund JAZZ -64.0 shares, $-6383.36 2020-03-31 N-PORT
FundVantage Trust- Gotham Defensive Long Fund JAZZ -33.0 shares, $-3291.42 2020-03-31 N-PORT
FORUM FUNDS- ABSOLUTE CONVERTIBLE ARBITRAGE FUND JAZZ -9503.0 shares, $-1568470.15 2020-12-31 N-PORT
FundVantage Trust- Gotham Index Plus All-Cap Fund JAZZ -76.0 shares, $-7580.24 2020-03-31 N-PORT
AMERICAN BEACON FUNDS- American Beacon SSI Alternative Income Fund JAZZ -7912.0 shares, $-1305875.6 2020-12-31 N-PORT
TRANSAMERICA FUNDS- Transamerica Event Driven JAZZ -1200.0 shares, $-186600.0 2021-01-31 N-PORT
Morningstar Funds Trust- Morningstar Alternatives Fund JAZZ -2464.0 shares, $-383152.0 2021-01-29 N-PORT
Calamos Investment Trust/IL- Calamos Market Neutral Income Fund JAZZ -71500.0 shares, $-11118250.0 2021-01-31 N-PORT
Columbia Funds Series Trust I- Multi-Manager Alternative Strategies Fund JAZZ -220.0 shares, $-36968.8 2021-02-28 N-PORT
ARBITRAGE FUNDS- WATER ISLAND CREDIT OPPORTUNITIES FUND JAZZ -1900.0 shares, $-319276.0 2021-02-28 N-PORT
ARBITRAGE FUNDS- THE ARBITRAGE FUND JAZZ -2568.0 shares, $-431526.72 2021-02-28 N-PORT
ARBITRAGE FUNDS- Water Island Event-Driven Fund JAZZ -213.0 shares, $-35792.52 2021-02-28 N-PORT
SARATOGA ADVANTAGE TRUST- James Alpha Multi Strategy Alternative Income Portfolio JAZZ -14.0 shares, $-2352.56 2021-02-28 N-PORT
Franklin Alternative Strategies Funds- Franklin K2 Alternative Strategies Fund JAZZ -5876.0 shares, $-987403.04 2021-02-26 N-PORT
GMO TRUST- GMO Implementation Fund JAZZ -4754.0 shares, $-798862.16 2021-02-28 N-PORT
GMO TRUST- GMO Alternative Allocation Fund JAZZ -2679.0 shares, $-450179.16 2021-02-28 N-PORT

Elevate your investments